Shanghai Micurx Pharmaceutical Co.,Ltd. Posted 173.8 Million Yuan Net Loss in First Three Quarters of 2022

Shanghai Micurx Pharmaceutical Co.,Ltd. (上海盟科药业股份有限公司) (688373.SH) reported a net loss of 173.8 million yuan in the first three quarters of 2022, widening 38.5% year-on-year.

Meanwhile, the company posted 34.9 million yuan in revenue, up 534.9% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 213.4 million yuan in total liabilities, with a liability-to-asset ratio of 14.5%.